MDB Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
MongoDB is a good buy right now for a beginner with a long-term horizon and substantial capital. The stock has strong analyst support, improving price targets, bullish hedge fund activity, and solid business momentum tied to Atlas and AI growth. Even though the short-term technical picture is mixed, the long-term setup is attractive enough to justify buying now rather than waiting.
MDB is trading in pre-market at 358.2, up 1.07%, with price near pivot resistance at 359.745. The trend structure is still constructive because SMA_5 is above SMA_20 and SMA_20 is above SMA_200, which supports a broader uptrend. However, MACD histogram is -2.27 and still expanding lower, showing near-term momentum weakness. RSI_6 at 52.845 is neutral, so the stock is not overbought. Support is at 318.478 and resistance is at 401.013. Overall, the longer-term trend is bullish, while short-term momentum is mixed.
["Multiple analysts raised price targets and maintained Buy/Outperform ratings.", "Tigress Financial sees a compelling multi-year upside opportunity and lifted its target to 515.", "Q1 results were described as a beat-and-raise quarter with Atlas growth around 29% year over year.", "Management commentary is increasingly positive on the AI opportunity.", "Hedge funds are buying aggressively, with buying up 273.15% over the last quarter."]
["MACD remains negative and is still weakening, signaling soft short-term momentum.", "Recent news includes a law-firm investigation into potential fiduciary duty issues, which is a mild governance overhang.", "Congress trading data shows 1 sale and no purchases in the last 90 days, suggesting caution from lawmakers.", "The stock has some near-term downside tendency based on similar pattern analysis, with a 60% chance of a slight next-day decline."]
Latest quarter: Q1 FY2027. The company reported strong results with a beat-and-raise quarter, Atlas growth around 29% year over year, and revenue guidance raised materially. Atlas growth also slightly accelerated year over year, which supports the view that core cloud database demand remains healthy. The latest quarter looks solid and confirms improving business momentum, especially in the AI and enterprise adoption themes.
Analyst sentiment is clearly positive and improving. Over the last two weeks, several firms raised price targets: Tigress to 515, Scotiabank to 395, Oppenheimer to 410, BMO to 375, Wedbush to 390, Morgan Stanley to 380, Needham to 400, Piper Sandler to 400, Stifel to 435, and Mizuho to 400. The consensus tone is bullish, with repeated Buy/Outperform/Overweight ratings and emphasis on Atlas strength, AI tailwinds, and continued execution. Wall Street pros are largely positive on MDB's long-term growth story, with the main pro view being durable Atlas growth and AI optionality, while the con side is that expectations are now higher and near-term price action can stay choppy.
